STOK
Stoke Therapeutics Inc
29.20$
+4.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +89.4% | +110.3% | +97.3% | +9.7% | +58.7% | +59.7% | -11.8% | -18.7% | |
| – | +823.1% | +700.8% | +200.1% | +185.2% | +38.9% | +10.5% | +8.8% | +17.4% | |
| – | +733.3% | +670.0% | +199.8% | +185.5% | +38.7% | – | – | – | |
| – | +3,425.8% | -201.1% | – | -98.0% | +93,428.3% | -114.0% | – | – | |
| – | +727.4% | +74.9% | -35.8% | +14.3% | +230.2% | -59.2% | -87.4% | +230.0% | |
| – | +718.6% | +76.6% | -35.7% | +7,178.7% | -40.0% | – | -201.4% | +73.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +1,833.7% | +31.2% | -28.9% | -98.8% | -17.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +1,835.7% | +29.5% | -27.8% | -98.8% | +3,514.4% | +14.2% | +147.3% | -25.7% | |
| – | +21,650.5% | +12.8% | -44.6% | -319.1% | – | – | -181.2% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.